Cargando…
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
CITE was a prospective, noninterventional study in adult patients with chronic immune thrombocytopenia treated with eltrombopag under routine clinical care in Asia-Pacific, the Middle East, and Turkey. Data to assess eltrombopag usage, compliance, and outcomes were collected from May 2017 to Decembe...
Autores principales: | Wong, Raymond Siu Ming, Yavaşoğlu, İrfan, Yassin, Mohamed A., Tarkun, Pınar, Yoon, Sung-Soo, Wei, Xie, Elghandour, Ashraf, Angchaisuksiri, Pantep, Ozcan, Mehmet, Yang, Renchi, Mattar, Mervat, Rahman, Masiur, Ingles, Sara, Goldbrunner, Michael, Frueh, Jennifer A., Jang, Jun Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469381/ https://www.ncbi.nlm.nih.gov/pubmed/36103340 http://dx.doi.org/10.1182/bloodadvances.2022008287 |
Ejemplares similares
-
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
por: Kaur, Manraj N., et al.
Publicado: (2022) -
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
por: Liu, Zhi-Jian, et al.
Publicado: (2021) -
COVID-19 vaccination in patients with immune thrombocytopenia
por: Visser, Chantal, et al.
Publicado: (2022) -
Expanding the genetic spectrum of TUBB1-related thrombocytopenia
por: Palma-Barqueros, Verónica, et al.
Publicado: (2021) -
Ribosome dysfunction underlies SLFN14-related thrombocytopenia
por: Ver Donck, Fabienne, et al.
Publicado: (2023)